Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | IGF1R | P08069 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4454748 | 0.89 | CA2 (0.42) | CA2GABRA1GABRB2ALDH1A1TDP1 | |
| SCHEMBL1264523 | 0.82 | CA2 (0.53) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL674008 | 0.82 | ALDH1A1 (0.52) | ALOX12ALDH1A1TDP1GLAL3MBTL1 | |
| SCHEMBL9825698 | 0.82 | ALDH1A1 (0.52) | ALOX12ALDH1A1TDP1GLAL3MBTL1 | |
| SCHEMBL12311837 | 0.81 | CA2 (0.44) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL6763906 | 0.80 | CYP1A2 (0.53) | ALDH1A1TDP1GLAL3MBTL1KDM4E | |
| SCHEMBL9445437 | 0.80 | CA2 (0.67) | CA2GABRA1GABRB2ALOX12ALDH1A1 | |
| SCHEMBL6723921 | 0.80 | RXRA (0.58) | CA2GABRA1GABRB2TDP1L3MBTL1 | |
| SCHEMBL19532868 | 0.79 | ALDH1A1 (0.42) | CA2GABRA1GABRB2ALDH1A1TDP1 | |
| SCHEMBL295470 | 0.79 | CA2 (0.64) | CA2GABRA1GABRB2ALOX12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108299263-A | A kind of derivatives of probucol and the preparation method and application thereof | 北京德默高科医药技术有限公司 | 2018-07-20 | — | — | CN | disclosed |
| EP-2110370-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-1348686-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-2110370-A1 | Method of producing p-hydroxyphenylalkanols | Sumitomo Chemical Company, Limited (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-6717020-B2 | HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-06 | — | — | US | disclosed |
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-16 | — | — | US | disclosed |
| EP-1348686-A1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | ADH1C, NR1H3, ADH5 | CA2 354/4885GABRA1 4187/4885GABRB2 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.